Global Genomics Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The Genomics Market size is expected to reach USD 207.70 Billion in 2034 from USD 50.67 Billion (2025) growing at a CAGR of 16.97% during 2026-2034.

The Global Genomics Market has witnessed significant expansion driven by advancements in DNA sequencing technologies and declining sequencing costs. Applications in precision medicine, drug discovery, agriculture, and biotechnology have broadened the market scope. Governments and private organizations are investing heavily in genomic research initiatives to improve disease diagnosis and treatment outcomes. The integration of genomics into clinical practice continues to accelerate adoption globally.

Key growth drivers include the increasing prevalence of chronic diseases, rising demand for personalized healthcare, and rapid innovation in next-generation sequencing technologies. Genomics plays a crucial role in identifying genetic disorders and guiding targeted therapies. Growing research collaborations and funding support are also strengthening market growth. Technological advancements such as gene editing and bioinformatics tools further enhance capabilities.

Looking forward, the genomics market is expected to grow at a strong pace as data analytics and artificial intelligence improve genomic interpretation. Expansion of precision medicine programs in emerging economies will create new opportunities. Ethical and regulatory frameworks will continue evolving to support innovation. Continued breakthroughs in gene therapy and molecular diagnostics will shape the future of the global genomics market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application & Technology

Functional Genomics
Epigenomics
Pathway Analysis
Biomarker Discovery

By Technology

Sequencing
PCR
Flow Cytometry
Microarrays
Other Technologies

By Deliverables

Products
Services

By End-use

Clinical Research
Academic & Government Institutes
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other End Users

COMPANIES PROFILED

Agilent Technologies, BioRad Laboratories Inc, BGI Genomics, Color Genomics Inc, Danaher Corporation, Eppendorf AG, Eurofins Scientific, F HoffmannLa Roche Ltd, GE Healthcare, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies

We can customise the report as per your requriements

Product Code: VMR11210539

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL GENOMICS MARKET: BY APPLICATION & TECHNOLOGY 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Application & Technology
4.2. Functional Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Epigenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Pathway Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.5. Biomarker Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENOMICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Technology
5.2. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Flow Cytometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENOMICS MARKET: BY DELIVERABLES 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Deliverables
6.2. Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENOMICS MARKET: BY END-USE 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast End-use
7.2. Clinical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Academic & Government Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.5. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.6. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENOMICS MARKET: BY REGION 2022-2034(USD MN)

8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Application & Technology
- 8.2.2 By Technology
- 8.2.3 By Deliverables
- 8.2.4 By End-use
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Application & Technology
- 8.3.2 By Technology
- 8.3.3 By Deliverables
- 8.3.4 By End-use
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Application & Technology
- 8.4.2 By Technology
- 8.4.3 By Deliverables
- 8.4.4 By End-use
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Application & Technology
- 8.5.2 By Technology
- 8.5.3 By Deliverables
- 8.5.4 By End-use
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Application & Technology
- 8.6.2 By Technology
- 8.6.3 By Deliverables
- 8.6.4 By End-use
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GENOMICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Company Profiles
- 10.2.1 Agilent Technologies
- 10.2.2 Bio-Rad Laboratories Inc
- 10.2.3 BGI Genomics
- 10.2.4 Color Genomics Inc
- 10.2.5 Danaher Corporation
- 10.2.6 Eppendorf AG
- 10.2.7 Eurofins Scientific
- 10.2.8 F. Hoffmann-La Roche Ltd
- 10.2.9 GE Healthcare
- 10.2.10 Illumina Inc
- 10.2.11 Myriad Genetics Inc
- 10.2.12 Oxford Nanopore Technologies